246 studies found for:    Open Studies | "Glaucoma"
Show Display Options
Rank Status Study
21 Recruiting The Flashing Light-Induced Pupil Response (FLIPR) Glaucoma Study
Conditions: Glaucoma, Open-Angle;   Eye Diseases
22 Recruiting 6-Week Proof-of-Concept Study of Travoprost/Brinzolamide Ophthalmic Suspension in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Conditions: Glaucoma;   Ocular Hypertension
Interventions: Drug: Dose Level A / Brinzolamide 1% ophthalmic suspension;   Drug: Dose Level B / Brinzolamide 1% ophthalmic suspension;   Drug: Dose Level C / Brinzolamide 1% ophthalmic suspension;   Drug: Brinzolamide 1% ophthalmic suspension AZOPT®;   Drug: Travoprost 0.004% ophthalmic solution TRAVATAN Z®;   Drug: Travoprost solution vehicle;   Drug: Brinzolamide suspension vehicle
23 Unknown  Intraocular Pressure (IOP) Lowering Effect of Selective Laser Trabeculoplasty Versus Prostaglandin Analogues in Angle Closure Glaucoma
Condition: Glaucoma
Interventions: Procedure: Selective Laser Trabeculoplasty;   Drug: Travoprost/ Timolol/ Azopt/ Brimonidine
24 Unknown  Corneal Endothelium After Glaucoma Surgery
Conditions: Glaucoma;   Corneal Damage;   Intraocular Pressure
25 Recruiting Phase IIA Double-Masked Randomized Sham-Controlled Trial of QPI-1007 Delivered by a Single Intravitreal Injection to Subjects With Acute Primary Angle-Closure Glaucoma (APACG)
Condition: Glaucoma, Angle-closure, Primary, Acute
Interventions: Drug: QPI-1007 Injection;   Drug: (including placebo)
26 Unknown  Comparison Between Deep Sclerectomy and Traditional Trabeculotomy & Trabeculectomy in Congenital Glaucoma
Condition: Congenital Glaucoma
Interventions: Procedure: Deep Sclerectomy;   Procedure: Combined Trab
27 Recruiting A 28 Day Study of ONO-9054 Ophthalmic Solution in Subjects With Ocular Hypertension (OHT) or Open-angle Glaucoma (OAG)
Conditions: Ocular Hypertension;   Open Angle-glaucoma
Interventions: Drug: ONO-9054;   Drug: Latanoprost
28 Recruiting Safety and Efficacy of Canaloplasty and Non-penetrating Deep Sclerectomy With Phacoemulsification to Treat Glaucoma and Cataract
Conditions: Open Angle Glaucoma;   Cataract
Interventions: Procedure: Canaloplasty and phacoemulsification;   Procedure: Non-penetrating deep sclerectomy and phacoemulsification
29 Unknown  Prevalence of Glaucoma in the Israeli Arab Population
Condition: Glaucoma
30 Unknown  Risk Factors for Glaucoma in Musicians
Condition: Glaucoma
31 Recruiting Glaucoma Treatment by Cyclo-coagulation Using High Intensity Focused Ultrasound (HIFU)
Condition: Glaucoma
Intervention: Device: EYEOP1
32 Recruiting Impact of Timolol/Dorzolamide Therapy on Autoregulation in Glaucoma Patients
Condition: Open Angle Glaucoma
Intervention: Drug: Administration of timolol 0.5% + dorzolamide 2% bid
33 Unknown  Subconjunctival Bevacizumab to Prevent Bleb Failure After Glaucoma Filtration Surgery
Condition: Glaucoma
Intervention: Drug: Subconjunctival Bevacizumab
34 Unknown  The Genetic Characteristics in South Korean Patients With Primary Congenital Glaucoma
Condition: Primary Congenital Glaucoma
35 Recruiting Safety and Efficacy of Deep Wave Trabeculoplasty (DWT) in Primary Open Angle Glaucoma and Ocular Hypertension
Conditions: Primary Open-angle Glaucoma (POAG);   Ocular Hypertension (OHT)
Interventions: Device: DWT device dose A;   Device: Ellex Tango SLT machine;   Device: DWT device dose B;   Device: DWT sham
36 Recruiting Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent Inject) or Travoprost
Condition: Open-angle Glaucoma
Interventions: Device: iStent inject;   Drug: Travoprost
37 Unknown  Ahmed Valve Glaucoma Implant With Adjunctive Subconjunctival Bevacizumab in Refractory Glaucoma
Condition: Refractory Glaucoma
Interventions: Drug: Subconjunctival Avastin;   Device: Ahmed Valve implant
38 Recruiting VISION5 Product Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular Hypertension
Conditions: Primary Open-Angle Glaucoma;   Ocular Hypertension
Interventions: Drug: VISION5 Product;   Drug: Timolol;   Drug: Placebo drops
39 Unknown  Efficacy of Retinal Nerve Fiber Layer (RNFL) / Retinal Thickness Ratio by Cirrus OCT Utilizing Spectral -Domain Technology as a Diagnostic Predictor of Glaucoma
Conditions: Glaucoma;   Myopia
40 Unknown  Instrument for Glaucoma Early Detection and Monitoring
Condition: Glaucoma
Intervention: Device: Glaucoma Diagnosis, Name: Neucodia

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years